NEW YORK, Jan. 13, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors of class action against Esperion Therapeutics, Inc. (Esperion or "the Company") (Nasdaq: ESPR) and certain of its officers. The class action was filed in the United States District Court for the Eastern District of Michigan on behalf of a class consisting of all persons or entities who purchased shares from August 18, 2015 through September 28, 2015, all dates inclusive (the "Class Period"). Such investors are advised to contact Peretz Bronstein or his investor relations analyst, Yael Hurwitz at email@example.com or 212-697-6484.
This lawsuit alleges that throughout the Class Period, Defendants released materially false and misleading statements regarding Esperion's business and prospects to shareholders, including that there was no clear path to approval for ETC-1002, and that the FDA had encouraged Esperion to initiate a cardiovascular outcomes trial ("CVOT") and the completion of a CVOT could be necessary prior to approval of ETC-1002. Following this news, Esperion stock traded at artificially inflated prices reaching as high as $82 per share in intra-day trading, causing investors to suffer losses.
No Class has yet been certified in the above action. If you wish to join this litigation you can visit the firm's website at: http://www.bgandg.com/#!espr/jfi4h. You may also contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Natural Health Trends you have until March 14, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | email@example.com
SOURCE Bronstein, Gewirtz & Grossman, LLC